Acute hyperenhancement on delayed contrast-enhanced magnetic resonance imaging is the characteristic sign after coronary microembolization
- PMID: 19323935
Acute hyperenhancement on delayed contrast-enhanced magnetic resonance imaging is the characteristic sign after coronary microembolization
Abstract
Background: Detection of coronary microembolization is of clinical importance for patient management and prediction of long-term outcome. However, there are few studies of the changes of magnetic resonance imaging after coronary microembolization. This study was designed to investigate the imaging of the left ventricle using delayed contrast enhanced magnetic resonance imaging as well as the left ventricular ejection fraction after coronary microembolization in animal models.
Methods: Eight miniswine, of either sex (body weight 21-25 kg), were used to make the coronary microembolization model. After coronary angiography, a 2.8F infusion catheter was placed in the left anterior descending artery with the tip located between the second and third diagonal branches. Microspheres with the diameter of 42 microm and mean dosage of 1.2 x 10(5) were selectively infused into the left anterior descending artery. First pass and stressed first pass perfusion scan were performed after cine images were acquired. Then a second bolus of 0.15 mmol/kg gadolinium DTPA was given at a rate of 2 ml/s. Ten minutes later, delayed contrast enhanced magnetic resonance images of the left ventricular wall were evaluated. Serum changes of tumor necrosis factor alpha (TNF-alpha) were evaluated by enzyme-linked immunosorbent assay (ELISA).
Results: Hypoenhancement was not observed at first pass perfusion at the anterior wall of the left ventricle. Hyperenhancements of the anterior-septal and anterior wall of the left ventricle was in evidence on delayed enhancement images 6 hours after microembolization and disappeared one week later. The characteristic change of coronary microembolization on delayed contrast enhanced magnetic imaging was non-enhanced regions within the hyperenhancement zone. Left ventricular ejection fraction measured by magnetic resonance imaging decreased significantly from 0.451 +/- 0.063 at baseline to 0.362 +/- 0.070 at the sixth hour (P < 0.01), and recovered to 0.431 +/- 0.053 one week later (P < 0.01 vs 6th hour). Compared with baseline values, the left ventricular end systolic volume enlarged significantly at 6th hour and at one week after microembolization (P < 0.05 and P < 0.01 respectively). Serum TNF-alpha increased significantly at 6th hour (22.62 +/- 6.96) pg/ml compared with baseline (16.83 +/- 3.45) pg/ml (P < 0.05) and it further increased to (27.44 +/- 3.97) pg/ml at one week after coronary microembolization and was significantly higher than that at baseline (P < 0.01).
Conclusions: On delayed contrast enhanced magnetic resonance imaging, hyperenhancement of the anterior-septal and anterior wall of the left ventricle show at 6th hour but not at one week after coronary microembolization. This might represent the characteristic imaging after coronary microembolization. The left ventricular ejection fraction decreased at 6th hour and recovered one week later after coronary microembolization. Although impairment of left ventricular function could be recovered at 1 week after coronary microembolization, the left ventricular remodeling process still continued in concert with continuously elevation of serum TNF-alpha.
Similar articles
-
Characterization of microvascular dysfunction after acute myocardial infarction by cardiovascular magnetic resonance first-pass perfusion and late gadolinium enhancement imaging.J Cardiovasc Magn Reson. 2006;8(6):831-7. doi: 10.1080/10976640600778049. J Cardiovasc Magn Reson. 2006. PMID: 17060106
-
The potential of contrast-enhanced magnetic resonance imaging for predicting left ventricular remodeling.J Magn Reson Imaging. 2002 Dec;16(6):633-40. doi: 10.1002/jmri.10206. J Magn Reson Imaging. 2002. PMID: 12451576
-
First-pass myocardial perfusion cardiovascular magnetic resonance at 3 Tesla.J Cardiovasc Magn Reson. 2007;9(4):633-44. doi: 10.1080/10976640601093661. J Cardiovasc Magn Reson. 2007. PMID: 17578718
-
["Dead or alive?": how and why myocardial viability imaging by cardiac MRI works].Rofo. 2007 Oct;179(10):1016-24. doi: 10.1055/s-2007-963199. Epub 2007 Jun 26. Rofo. 2007. PMID: 17594631 Review. German.
-
[Optimal use of contrast medium in contrast enhanced MR imaging of the heart].Nihon Igaku Hoshasen Gakkai Zasshi. 2002 Oct;62(12):682-9. Nihon Igaku Hoshasen Gakkai Zasshi. 2002. PMID: 12462069 Review. Japanese.
Cited by
-
MRI monitoring of function, perfusion and viability in microembolized moderately ischemic myocardium.Int J Cardiovasc Imaging. 2015 Aug;31(6):1179-90. doi: 10.1007/s10554-015-0673-3. Epub 2015 May 8. Int J Cardiovasc Imaging. 2015. PMID: 25951916
-
MRI quantification of left ventricular function in microinfarct versus large infarct in swine model.Int J Cardiovasc Imaging. 2013 Jan;29(1):159-68. doi: 10.1007/s10554-012-0076-7. Epub 2012 Oct 13. Int J Cardiovasc Imaging. 2013. PMID: 23065097
-
Changes in left ventricular ejection fraction and coronary flow reserve after coronary microembolization.Arch Med Sci. 2012 Feb 29;8(1):63-9. doi: 10.5114/aoms.2012.27283. Arch Med Sci. 2012. PMID: 22457677 Free PMC article.
-
Left ventricular remodeling with preserved function after coronary microembolization: the effect of methylprednisolone.Eur J Med Res. 2014 Feb 4;19(1):7. doi: 10.1186/2047-783X-19-7. Eur J Med Res. 2014. PMID: 24495645 Free PMC article.
-
Establishment of a Novel Mouse Model of Coronary Microembolization.Chin Med J (Engl). 2016 Dec 20;129(24):2951-2957. doi: 10.4103/0366-6999.195469. Chin Med J (Engl). 2016. PMID: 27958227 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical